Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2026-06-02 @ 7:48 AM
Study NCT ID:
NCT04877457
Status:
TERMINATED
Last Update Posted:
2024-10-09
First Post:
2021-04-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.
Sponsor:
Yale University
Organization: